Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take Mounjaro for weight management and you're thinking about giving blood, the short answer is that NHS Blood and Transplant currently asks donors to wait before donating after taking tirzepatide — but the details matter, and the guidance can change. Mounjaro is a prescription-only medicine and a prescriber decides whether it's right for you; tirzepatide itself won't hurt the person receiving your blood, but donation services apply precautionary deferrals while a medicine is newly established in clinical use.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a situation a good number of donors face. You've been taking Mounjaro for a few months, feeling well, and you want to get back to giving blood. You search the NHS Blood and Transplant medicines list, find tirzepatide flagged, and suddenly the slot you booked feels uncertain.
This is a question our prescribers hear most weeks, so it's worth being clear about what the deferral actually means. NHS Blood and Transplant maintains a medicines deferral list as a precautionary measure. When a medicine is relatively new to widespread use (and Mounjaro has only been widely prescribed in the UK since 2023) donor services defer donors for a set period to allow time for transfusion safety data to accumulate. It is not a signal that your blood is unsafe or that tirzepatide causes any known harm to transfusion recipients. It is, quite simply, a cautious default while the evidence base matures.
The practical upshot: if you are currently taking Mounjaro, check the NHSBT medicines list before booking. The deferral window is subject to review, and NHSBT updates its guidance periodically. Donor eligibility is also assessed on the day, so declaring your current medicines at every session is non-negotiable.
Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, which slow gastric emptying, reduce appetite and support blood-sugar regulation. It circulates in plasma and has a half-life of roughly five days, which is why any deferral period extends beyond the last dose. Tirzepatide's pharmacological profile is well understood for therapeutic use, but transfusion medicine works to a different standard: the question is not whether the medicine is effective, but whether trace levels in donated plasma could theoretically affect a recipient.
There is no published evidence that tirzepatide in donated blood causes harm. The deferral reflects the absence of long-term transfusion data, not the presence of a known risk. That distinction is important, particularly for donors who feel well and want to understand why a medicine they are taking for a health condition affects their eligibility.
The NHS medicines page for tirzepatide covers how the medicine works and its general safety profile, which is a useful starting point if you want to understand the background before speaking to donor services.
If you have discontinued Mounjaro, the deferral period typically begins from your last dose. Most donor services calculate eligibility from that point, so a gap of several months after stopping may restore your ability to donate, depending on what NHSBT's current guidance says at the time you present. You can explore the specific eligibility scenarios in more detail on this page on giving blood while on Mounjaro and on the related page covering the question from another angle.
The honest answer is that NHSBT guidance evolves. The only reliable check is the current NHSBT medicines list on the day you intend to donate, not a forum post, not a leaflet from a year ago. If you are uncertain, NHSBT has a donor helpline and staff at each session will make the final assessment.
One more practical note: if you are considering Mounjaro for weight management and are a regular donor, raise the point during your free consultation. A prescriber can talk through the timing alongside your health goals, so you can plan around donation seasons rather than being caught off guard.
Some people searching on this topic are actually thinking about routine blood tests rather than donation, monitoring bloods, liver function, kidney function, or cholesterol checks that often accompany weight-management treatment. These are entirely different from blood donation. Routine clinical blood tests are not affected by the donation deferral rules, and your GP or prescriber may recommend monitoring bloods at certain points in your treatment. The Mounjaro blood test page covers that topic separately if it is what you were looking for.
For people thinking about cost alongside these questions, the private cost of Mounjaro in the UK is a topic we cover in detail, including what a legitimate price should include. Treatment at nume is priced as one transparent amount covering consultation, prescription, dispensing, and free next-working-day delivery, no subscription and no surprise fees.
If you have other questions about taking Mounjaro, our FAQs cover a broad range of practical scenarios, or you can reach the team directly. Every prescription at nume is reviewed by a GPhC-registered Independent Prescriber before anything is dispensed, a real clinician, not software, reading your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.